Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1977-4-25
pubmed:abstractText
Using His bundle recording techniques, we examined direct and autonomically mediated conduction system effects of quinidine in five cardiac transplant recipients who have anatomically denervated hearts. We made control conduction interval and refractory period measurements, and then infused 10 mg/kg quinidine gluconate over a 20-min period. At 30 min, we determined the electrophysiologic changes induced by quinidine. Quinidine significantly increased the atrial-His (AH) interval (from 97+/-9 [SEM] to 108+/-7 ms, P less than 0.001), the His-ventricular (HV) inteval (from 43.9 +/- 1 to 52.8 +/- 3 ms, P less than 0.01), the donor heart sinus cycle length (from 599 +/- 38 to 630 +/- 56 ms, P less than 0.08), and the atrial effective refractory period (from 214 +/- 14 to 241 +/- 11 ms, P less than 0.01). Quinidine significantly decreased the innervated, remnant atrial sinus cycle length (from 847 +/- 104 to 660 +/- 96 ms, P less than 0.01) and the blood pressure. The mean plasma concentration of quinidine at the time that electrophysiologic measurements were repeated was 4.37 +/- 0.449 micrograms/ml. We conclude that quinidine's predominant sinus nodal and atrioventricular nodal effects in man are autonomically mediated and opposite to its direct actions upon these structures. On the other hand, quinidine's prevailing effect on atrial refractoriness and His-Purkinje conduction in man is direct.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-1089491, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-1096907, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-1106169, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-13931458, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-14086332, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-14171997, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-14237425, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-14908858, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-15409761, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-4108657, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-4430098, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-4555848, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-4563213, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-4568360, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-4686607, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-4817489, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-5561417, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-5954128, http://linkedlifedata.com/resource/pubmed/commentcorrection/320227-769517
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
481-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1977
pubmed:articleTitle
The electrophysiologic effects of quinidine in the transplanted human heart.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.